DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: Neurofibromatosis type 1 gene as a model

Clinical Chemistry

Volumn 56, Issue 1, 2010, Pages 62-72

  Chou, Lan Szu ^a   Liu, C S Jonathan ^b   Boese, Benjamin ^c   Zhang, Xinmin ^d   Mao, Rong ^a,e  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b SoftGenetics LLC   (United States)

^c A Roche Company   (United States)

^d Roche NimbleGen Inc   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NEUROFIBROMIN; OLIGONUCLEOTIDE;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; GENE MAPPING; GENE TARGETING; GENOME; GENOTYPE; HUMAN; MOUSE; NONHUMAN; PSEUDOGENE;

GENES, NEUROFIBROMATOSIS 1; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSEUDOGENES; SEQUENCE ANALYSIS, DNA;

EID: 73449142861     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.132639     Document Type: Article

References (37)

1. Asmann YW, Wallace MB, Thompson EA. Transcriptome profiling using next-generation sequencing. Gastroenterology 2008;135:1466-8.
2. Holt RA, Jones SJ. The new paradigm of flow cell sequencing. Genome Res 2008;18:839-46.
3. Marguerat S, Wilhelm BT, Bahler J. Nextgeneration sequencing: applications beyond genomes. Biochem Soc Trans 2008;36:1091- 6.
4. Morozova O, Marra MA. Applications of nextgeneration sequencing technologies in functional genomics. Genomics 2008;92:255- 64.
5. Wheat CW. Rapidly developing functional genomics in ecological model systems via 454 transcriptome sequencing. Genetica [Epub ahead of print 2008 Oct 18].
6. Aartsma-Rus A, van Ommen GJ. Antisensemediated exon skipping: a versatile tool with therapeutic and research applications. RNA 2007; 13:1609 -24.
7. Madden HR, Fletcher S, Davis MR, Wilton SD. Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping. Hum Mutat 2009;30:22- 8.
8. Wee KB, Pramono ZA, Wang JL, MacDorman KF, Lai PS, Yee WC. Dynamics of co-transcriptional pre-mRNA folding influences the induction of dystrophin exon skipping by antisense oligonucleotides. PLoS One 2008;3:e1844.
9. Wilton SD, Fletcher S. Redirecting splicing to address dystrophin mutations: Molecular by-pass surgery. Prog Mol Subcell Biol 2006;44:161-97.
10. ten Bosch JR, Grody WW. Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. J Mol Diagn 2008;10: 484 -92.
11. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG, et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005;307:1072-9.
12. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987;155:335-50.
13. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268 -74.
14. Bau S, Schracke N, Kränzle M, Wu H, Stähler PF, Hoheisel JD, et al. Targeted next-generation sequencing by specific capture of multiple genomic loci using low-volume microfluidic DNA arrays. Anal Bioanal Chem 2009;393:171-5.
15. Albert TJ, Molla MN, Muzny DM, Nazareth L, Wheeler D, Song X, et al. Direct selection of human genomic loci by microarray hybridization. Nat Methods 2007;4:903-5.
16. Antson DO, Isaksson A, Landegren U, Nilsson M. PCR-generated padlock probes detect single nucleotide variation in genomic DNA. Nucleic Acids Res 2000;28:E58.
17. Gnirke A, Melnikov A, Maguire J, Rogov P, Le-Proust EM, Brockman W, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009;27:182-9.
18. Larsson C, Koch J, Nygren A, Janssen G, Raap AK, Landegren U, Nilsson M. In situ genotyping individual DNA molecules by target-primed rollingcircle amplification of padlock probes. Nat Methods 2004;1:227-32.
19. Hodges E, Xuan Z, Balija V, Kramer M, Molla MN, Smith SW, et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet 2007; 39:1522-7.
20. Porreca GJ, Zhang K, Li JB, Xie B, Austin D, Vassallo SL, et al. Multiplex amplification of large sets of human exons. Nat Methods 2007;4: 931-6.
21. Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet 2008;24:133- 41.
22. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62:187-92.
23. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599-608.
24. Lee MJ, Stephenson DA. Recent developments in neurofibromatosis type 1. Curr Opin Neurol 2007; 20:135- 41.
25. Suzuki Y, Suzuki H, Kayama T, Yoshimoto T, Shibahara S. Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain. Biochem Biophys Res Commun 1991;181:955-61.
26. Li Y, O'Connell P, Breidenbach HH, Cawthon R, Stevens J, Xu G, et al. Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 1995;25:9 -18.
27. Kehrer-Sawatzki H, Schwickardt T, Assum G, Rocchi M, Krone W. A third neurofibromatosis type 1 (NF1) pseudogene at chromosome 15q11.2. Hum Genet 1997;100:595- 600.
28. Luijten M, Redeker S, Minoshima S, Shimizu N, Westerveld A, Hulsebos TJ. Duplication and transposition of the NF1 pseudogene regions on chromosomes 2, 14, and 22. Hum Genet 2001;109: 109-16.
29. Suzuki H, Ozawa N, Taga C, Kano T, Hattori M, Sakaki Y. Genomic analysis of a NF1-related pseudogene on human chromosome 21. Gene 1994;147:277- 80.
30. Roche NimbleGen. Technical note: Roche Nimble-Gen probe design fundamentals. http://www.nimblegen.com/products/lit/probe-design-2008-06-04.pdf (Accessed November 2009).
31. Roche NimbleGen. NimbleGen services user's guides: sequence capture service. http://www. nimblegen.com/products/lit/SeqCap-UsersGuide-Service-v3p0. pdf (Accessed November 2009).
32. Roche Diagnostics, Roche Applied Science. GS FLX shotgun DNA library preparation method manual: December 2007. http://www.unc.edu/ htsf/files/GSFLXShotgunDNA-Library-Preparation-Method-Manual-CD.pdf (Accessed November 2009).
33. Roche Diagnostics, Roche Applied Science. GS FLX emPCR method manual: December 2007. ftp://ftp.genome.ou.edu/pub/for-broe/FLX/9.%20GS %20FLX%20emPCR%20Method%20Manual.pdf (Accessed November 2009).
34. Wallace MR, Andersen LB, Saulino AM, Gregory PE, Glover TW, Collins FS. A de novo Alu insertion results in neurofibromatosis type 1. Nature 1991; 353:864-6.
35. Smith DR, Quinlan AR, Peckham HE, Makowsky K, Tao W, Woolf B, et al. Rapid whole-genome mutational profiling using next-generation sequencing technologies. Genome Res 2008;18: 1638-42.
36. Colman SD, Collins FS, Wallace MR. Characterization of a single base-pair deletion in neurofibromatosis type 1. Hum Mol Genet 1993;2: 1709-11.
37. Wimmer K, Yao S, Claes K, Kehrer-Sawatzki H, Tinschert S, De Raedt T, et al. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer 2006;45: 265-76.